NCT04116281

Brief Summary

Objectives: To evaluate the pressure pain threshold, shoulder biomechanics, cardiorespiratory function and the quality of life associated with the short and long-term physical therapy rehabilitation following breast cancer surgery. Methodology: The study presents three objectives and involves three groups of participants. Objective 1 is to develop a topographic map of pressure pain in the shoulder (using a digital pressure algometer), evaluate the biomechanics of the shoulder (using a digital inclinometer and load card), cardiorespiratory function (through frequency variability resting heart rate and distance traveled, through the six-minute walk test) and quality of life (through questionnaires of quality of life, anxiety, depression, sleep quality, upper limb functionality, fatigue and level of physical activity) between a group of women prior to the operation of breast cancer (experimental group, n = 36) and a group of asymptomatic controls for shoulder pain (control group, n = 18). Objective 2 is to evaluate the possible changes in the pain map over 24 weeks of supervised kinetic intervention (Supervised Physiotherapy experimental group, n = 18, will begin after drainage, frequency 3 times per week and duration of 60 minutes each session) compared to unsupervised kinetic intervention (Home Physiotherapy experimental group, n = 18, participants will receive an exercise booklet). Objective 3 is to evaluate the biomechanics of the shoulder, cardiorespiratory function and the quality of life with respect to the experimental group with and without kinesic supervision. To achieve objective 1, two baseline evaluations will be carried out in both experimental and control groups (considering the month prior to the surgery of the experimental group) and the average of the evaluations will be considered evaluation 1. To achieve objectives 2 and 3, evaluation 2 (after 4 weeks of intervention), 3 (after 12 weeks of intervention) and 4 (after 24 weeks of intervention) will be performed. The statistical analysis will include the examination of qualitative and quantitative variables. Statistical tests will be applied according to the normality of the data and a significance level of 5% will be adopted for all comparisons. Expected results: It is expected to identify sensory, biomechanical, cardiorespiratory and quality of life alterations in the experimental group, compared to the control group. In addition, after 24 weeks of intervention, the supervised experimental group will show improvement in all the aforementioned variables with respect to the unsupervised group.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
36

participants targeted

Target at below P25 for not_applicable breast-cancer

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable breast-cancer

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 4, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

December 2, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
3.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 25, 2024

Completed
Last Updated

July 12, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

September 29, 2019

Last Update Submit

July 9, 2022

Conditions

Keywords

Upper limb functionHeart hate variabilityPhysical therapyBreast neoplasmsPressure pain thresholdPerceived pain

Outcome Measures

Primary Outcomes (4)

  • Pressure pain threshold over the shoulder of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    This outcome will involve data regarding to pressure pain threshold assessment over the shoulder at three and six monthes of treatment.

    Three months

  • Pressure pain threshold over the shoulder of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    This outcome will involve data regarding to pressure pain threshold assessment over the shoulder at three and six monthes of treatment.

    Six months

  • Strength grip of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    This outcome will involve data regarding to objective measurement that consist in to do a maximal strenth grip. The unity of measurement it is in kg.

    Three months

  • Strength grip of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    This outcome will involve data regarding to objective measurement that consist in to do a maximal strenth grip. The unity of measurement it is in kg.

    Six months

Secondary Outcomes (10)

  • Upper limb functionality of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    Three months

  • Upper limb functionality of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    Six months

  • Fatigue of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    Three months

  • Fatigue of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    Six months

  • Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery.

    Three months

  • +5 more secondary outcomes

Study Arms (2)

Supervised group

EXPERIMENTAL

Supervised group

Other: Rehabilitation after breast cancer surgery

No supervised group

OTHER

Control group

Other: Rehabilitation after breast cancer surgery

Interventions

All participants are going to receive physical therapy intervention after breast cancer surgery at least removal drenaige. After that, will be randomized in two groups: Group 1 are going to receive a physical therapy program supervised by a physiotherapist; Group 2 are going to receive some instructions about the same program to perfomr at home without supervision. Both groups are going to receive 3 and 6 months of rehabilitation program.

No supervised groupSupervised group

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Surgical indication of conservative or removal breast surgery, associated with axillary lymphadenectomy or sentinel lymph node biopsy
  • Any type of breast cancer
  • Age range over 18 years

You may not qualify if:

  • Breast cancer recurrence;
  • Surgical treatment for bilateral breast cancer;
  • Presence of lymphedema in the upper limb, measured by means of cirtometry of the upper limb with a measuring tape 14, asymmetries of more than 1.5 cm between the limbs were considered edema;
  • Diagnosis of metastases;
  • Shoulder pain compatible with shoulder compression symptoms as determined by the positive Hawkins-Kennedy test 30;
  • Previous history of surgery and fractures in the upper extremities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catholic University of Maule

Talca, Maule Region, 3600000, Chile

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Ivana L Ribeiro, PhD

    Universidad Católica del Maule

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 29, 2019

First Posted

October 4, 2019

Study Start

December 2, 2019

Primary Completion

May 30, 2020

Study Completion

February 25, 2024

Last Updated

July 12, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

Locations